STAGE IV ESOPHAGEAL CANCER AJCC V7
Clinical trials for STAGE IV ESOPHAGEAL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV ESOPHAGEAL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV ESOPHAGEAL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to slow advanced esophageal cancer
Disease control OngoingThis study tested if adding an experimental drug called cixutumumab to standard chemotherapy (paclitaxel) could better control cancer that had spread or returned. It involved 94 adults with advanced esophageal or gastroesophageal junction cancer whose initial treatment had stoppe…
Matched conditions: STAGE IV ESOPHAGEAL CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 00:50 UTC
-
New pill aims to supercharge radiation against tough cancers
Disease control OngoingThis early-stage study is testing a new oral drug called ropidoxuridine (IPdR) in patients with advanced gastrointestinal cancers that have spread. The main goal is to find the safest dose of the drug when taken daily alongside standard radiation therapy. Researchers hope the dru…
Matched conditions: STAGE IV ESOPHAGEAL CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC